Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Health, Israel | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To explore whether recombinant LH (rLH) supplementation (Leuveris) to recombinant follicle stimulating hormone (rFSH) following GnRH antagonist treatment has an advantage in infertile women with advanced reproductive ageing undergoing IVF-ET.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 60 infertile women | Experimental | Candidates for IVF-ET treatment |
|
| control | No Intervention | no treatment |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Leuveris | Drug | IV |
| |
| Leuveris |
| Measure | Description | Time Frame |
|---|---|---|
| Pregnancy rate | Starting February 2010 |
| Measure | Description | Time Frame |
|---|---|---|
| Fertilization rate | Starting February 2010 till April 2013 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Poriya hospital | Tiberias | 15208 | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
All recruited women will be treated similarly employing the recombinant FSH and the fixed GnRH antagonist. Concomitantly, on the same day of the antagonist administration r-LH will be administered daily and continued until human chorionic gonadotropin (hCG) day. |
|